ProRx LLC recalls Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL
- Company
- ProRx LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 37 vials
- About this recall
- Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01